Home > Healthcare & Medical Devices > Stroke Management Market

Stroke Management Market Size By Type (Ischemic, Hemorrhagic, Transient Ischemic Attack {TIA}), By Product (Diagnostic Devices {Magnetic Resonance Imaging, Computed Tomography Scan, Electrocardiography, Carotid Ultrasound, Cerebral Angiography}, Therapeutic Devices {Stent Retriever, Surgical Clips, Embolic Coils, Flow Diverters, Aspiration Catheters}), By End-use (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI3550
  • Published Date: Sep 2021
  • Report Format: PDF

Industry trends

Stroke Management Market size valued at over USD 31 billion in 2020 and is anticipated to grow at a CAGR of more than 6% between 2021 and 2027. With increasing product development activities and growing awareness among the population, the market will witness lucrative growth in the coming years.

Stroke Management Market Overview

Get more details on this report - Request Free Sample PDF

Growing geriatric population base and increasing prevalence of cardiovascular diseases will majorly drive the stroke management market expansion. In Europe, 56% of patients diagnosed with aortic valve stenosis were aged over 70 years. Moreover, several government organizations have initiated awareness programs to reduce frequency of stroke among elderly population. For instance, in the U.S., the Patient Protection and Affordable Care Act (ACA) offers health coverage to more than 20 million citizens including the elderly.

Innovations in stroke management devices along with rising demand for cardiac surgeries will augment the market progression. Some of the key players in market are focusing on development of novel stroke treatment products. For instance, Terumo Corporation announced about the product clearance by the U.S. FDA for its SOFIA catheter developed for distal navigation and successful revascularization of patients. Commercialization of such advanced interventional devices enable faster patient recovery.

Stroke management market has experienced slightly negative impact during the pandemic. In March 2020, nearly 28% visits to the emergency department for stroke management was decreased in Italy due to hospital avoidance of stroke patients and stay-at-home appeal. However, the patients suffering from cerebrovascular and neurovascular diseases are subject to high risk of COVID-19 infection. Thus, the adoption rate of stroke management devices is expected to spur significantly in the coming years.

Growing prevalence of ischemic stroke among geriatric population will offer several growth opportunities

Stroke Management Market Size

Get more details on this report - Request Free Sample PDF

Ischemic segment dominated more than 80% of the stroke management market share in 2020. According to the World Stroke Organization, around 60% of new cases related to ischemic stroke occur in individuals till the age 70 years globally. In addition, several market leaders are involved in development of devices to treat ischemic stroke. Medtronic launched Solitaire X, a revascularization device for treatment of acute ischemic stroke.

Several advantages associated with CT scans over other imaging modalities is set to foster the industry growth

Diagnostic devices segment in the stroke management market is slated to showcase 5.9% growth rate through 2027. Among diagnostic devices, computed tomography scan (CT scan) accounted for highest revenue share in 2020. CT scan helps in early diagnosis of diseases. Thus, continuous advancement in CT scanners for better visualization is projected to boost the segment growth during the forecast period.

Rising preference of patients towards hospitals for stroke-related assistance will fuel the market demand

Hospitals segment is estimated to reach USD 18 billion by 2027. High spending capacity of hospitals on innovative devices coupled with presence of skilled expertise is a primary factor impelling the segment revenue. Adding to this, increasing number of patient visits to multispecialty as well as small-sized hospitals will stimulate the segment value.

Increasing prevalence of stroke will continue to strengthen the industry expansion in North America region

North America Stroke Management Market

Get more details on this report - Request Free Sample PDF


North America stroke management market accounted for over 32% of revenue share in 2020 owing to the growing prevalence of cardiac diseases. As per the Centers for Disease Control and Prevention, every year more than 795,000 people in the U.S. suffer from stroke. Further, growing incidence of obesity, changing lifestyle, and unhealthy dietary habits add to risk factors of stroke. Additionally, high spending capacity and increasing R&D will positively impact the regional growth.

Product innovations and partnerships to widen offerings are assisting the firms in business expansion

The global stroke management market consists of several players including Abbott, Asahi Intecc CO., LTD, Boston Scientific Corporation, GE Healthcare, Johnson & Johnson, Medtronic, Penumbra, Inc. and Siemens AG among others. These companies are adopting several expansion and growth strategies such as partnerships, acquisitions and product launches to increase their market presence.

Some of the recent industry developments:

  • In September 2020, Johnson & Johnson announced the launch of Cerenovus Stroke Solutions that includes a suite of three devices intended to assist physicians in clot removal procedures. This product launch helped the company in strengthening its stroke management product portfolio and generating significant revenue.
  • In April 2019, Medtronic announced the launch of Solitaire X, a revascularization device use in patients for the treatment of acute ischemic stroke. This product launch helped the company to expand its product portfolio.

The stroke management market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Type

  • Ischemic
  • Hemorrhagic
  • Transient Ischemic Attack
  • Others

Market, By Application

  • Diagnostic Devices
    • Magnetic Resonance Imaging
    • Computed Tomography Scan
    • Electrocardiography
    • Carotid Ultrasound
    • Cerebral Angiography
    • Others
  • Therapeutic Devices
    • Stent Retriever
    • Surgical Clips
    • Embolic Coils
    • Flow Diverters
    • Aspiration Catheters
    • Others

Market, By End-use

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Poland
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Malaysia
    • Thailand
    • Indonesia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Qatar
    • UAE


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The market size of stroke management was over USD 31 billion during 2020 and is expected to witness nearly 6% CAGR through 2021-2027.

Ischemic strokes segment held over 80% of revenue share in 2020 and will expand with increasing geriatric population worldwide and consistent development of treatment devices.

Diagnostic devices segment will register around 5.9% CAGR up to 2027 with the demand for solutions like CT scans, carotid resonance, magnetic resonance imaging, electrocardiography, among others.

North America held nearly 32% of the market share in 2020 and will grow due to increased cases of obesity and high investments in healthcare R&D projects.

Major companies in industry include GE Healthcare, Medtronic, Abbot, Boston Scientific Corporation, Johnson & Johnson, Penumbra, Inc. and a few others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2020
  • Companies covered: 14
  • Tables & Figures: 381
  • Countries covered: 25
  • Pages: 280

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount